We are Sorry, This Page doesn't Exist
Commit To Buy Emergent BioSolutions At $40, Earn 7.1% Annualized Using Options
Stock Options Channel.....»»
Commit To Buy Emergent BioSolutions At $55, Earn 10.2% Annualized Using Options
Stock Options Channel.....»»
100 million doses of Johnson & Johnson"s vaccine need to be checked for contamination and may need to be thrown out
The millions of Johnson & Johnson COVID-19 vaccine doses haven't been distributed to the public and are from a plagued Emergent BioSolutions facility. Employees wor.....»»
The Wall Street Journal: Emergent CEO says company made over 100 million doses of J&J vaccine, apologizes for contaminated batch
Emergent BioSolutions Inc. has made enough of a key ingredient to yield more than 100 million doses of Johnson & Johnson’s Covid-19 vaccine, and federal health regulators are evaluating whether to release the shots, Emergent’s chief executive said......»»
Emergent BioSolutions gave top executives bonuses, NYT reports
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Emergent shares slide 2.8% as execs blame J&J vaccine snafu on challenge of making two vaccines to scale
Emergent BioSolutions Inc. executives said part of the blame for a snafu in manufacturing the COVI.....»»
Johnson & Johnson documented contamination risks at Baltimore plant months before vaccine was ruined
The House Oversight select subcommittee on the coronavirus crisis is investigating events at Emergent BioSolutions that led to a vaccine production shutdown that is now in its fifth week......»»
Baltimore biodefense executives face grilling in Congress over botched production of J&J vaccine
The House Select Subcommittee on the Coronavirus Crisis is investigating events at Emergent BioSolutions that led to a vaccine production shutdown that is now in its fifth week......»»
Johnson & Johnson vaccine shipments to states dwindle to zero as production freeze continues
Allocations to states of Johnson & Johnson's one-shot vaccine dry up after contamination crisis at Baltimore subcontractor Emergent BioSolutions.....»»
Emergent BioSolutions price target lowered to $64 from $70 at Wells Fargo
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Emergent BioSolutions downgraded to Hold from Buy at Argus
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Emergent BioSolutions downgraded to Hold from Buy at Argus
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Emergent BioSolutions Has Supply Of 60M Johnson & Johnson COVID-19 Vaccine Doses Awaiting Approval: Bloomberg
read more.....»»
Emergent BioSolutions Hopeful To Restart Vaccine Production, Plans To Submit Response To FDA Within Days
read more.....»»
Emergent BioSolutions price target lowered to $92 from $112 at Chardan
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Emergent BioSolutions ‘hopeful’ to return to vaccine production, plans to submit response to FDA ‘within days’
On a first-quarter earnings call Thursday, Emergent's CEO addressed a turbulent month for the Gaithersburg biopharmaceutical company......»»
Emergent BioSolutions price target lowered to $120 from $150 at Benchmark
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Emergent BioSolutions CEO shakes up executives, but defends company
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Emergent BioSolutions reports Q1 adjusted EPS $1.28, consensus $1.12
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
CEO of COVID-19 vaccine maker sold $10M in stock before company destroyed Johnson & Johnson doses
The CEO of Emergent BioSolutions, the government contractor that destroyed 15 million doses of Johnson & Johnson's COVID-19 vaccine, sold more than $10 million worth of his stock in the company before its share prices plummeted......»»